Exclusive Online Content
Targeted Lung Cancer Therapies Are Supplanting Conventional Treatments
Although lung cancer is the third most prevalent cancer type in the world, there are only 18 drugs in the market for its treatment. Further,…
PBOA Supports FDA SOS Act
The Pharma & Biopharma Outsourcing Association (PBOA) praises Representatives Lance (R-NJ) and Anna Eshoo (D-CA) for introducing the FDA Safety Over Sequestration Act, or FDA…
Japanese Pharmaceutical Market Value Edging Toward $80 Billion
Japan’s pharmaceutical market value is set to grow at a tepid Compound Annual Growth Rate (CAGR) of 1.3% from $72.8 billion in 2013 to reach…
Ball Corporation Confirms Acquisition Terms of Rexam PLC
Ball Corporation and Rexam PLC recently announced the terms of a recommended offer by Ball to acquire all of the outstanding shares of Rexam in…
Aegis Awarded US Patent for Non- Invasive Delivery of Anti-Seizure Drugs
Aegis Therapeutics LLC recently announced it has been awarded US Patent No. 8,927,497 providing broad coverage for non-invasive delivery of anti-seizure drugs via a simple…
Senior Pharmaceutical Industry Executives Establish New Company & Business Model
Three highly experienced pharmaceutical and healthcare industry executives have formed next20, a new Thought Partnership, which provides strategic support to help healthcare and pharmaceutical companies…
Growth Hormone Therapy Market Favors Biobetters Over Biosimilars
The lack of biosimilars in the growth hormone deficiency (GHD) treatment pipeline does not signify a missed opportunity, because superior products exist in the form…
New Parsum IPP-80 In-Line Particle Sizing Probe: Robust, Trouble-Free Granulation Monitoring
The new Parsum IPP-80 probe from Malvern Instruments brings easy to integrate inline particle size measurement for efficient process monitoring and control. Suitable for powders,…
Needle-Free Technologies the Preferred Choice for Patients
BCC Research reveals in its new report on needle free technologies that during the past several decades, tremendous progress has been made toward the development…
With Stiff Competition From Biosimilars, Antibody Drugs Industry Revamping With Targeted Treatments
BCC Research reveals in its new report on antibody drugs that increasing competition and new technologies are propelling the market in a new direction. This…
Biological Therapies in Cancer Treatment to Reach $66 Billion in 2019
BCC Research reveals in its new report on biologic cancer treatment that access and affordability of cancer treatment options in various countries, along with a…
NanoSmart Receives FDA Orphan Drug Designation for ANA-Conjugated Liposomal Doxorubicin for the Treatment of Ewing's Sarcoma
LAGUNA HILLS, CA, February 9, 2015 – NanoSmart® Pharmaceuticals, Inc., a private pharmaceutical company developing nanoparticle drug delivery platforms, has received Orphan Drug Designation from…
GlaxoSmithKline Encounters Initial Resistance Following Directional Shift
Following a less than flattering financial performance in 2014, GlaxoSmithKline plc (GSK) is realigning its operating structure with its corporate objectives and cashing in on…
Technological Breakthroughs Aiding the Biologics Market
BCC Research reveals in its new report on biologic therapeutic drugs, the biologics or biopharmaceutical therapeutic market holds important implications for the future of medicine…
HER2-Negative Breast Cancer Treatment Market Value to Reach $6.12 Billion
The market value for HER2-negative breast cancer therapeutics will increase more than fourfold, from $1.45 billion in 2013 to an estimated $6.12 billion by 2023,…
Sanofi & MannKind Announce Afrezza, the Only Inhaled Insulin, Now Available in the US
Sanofi and MannKind Corporation announced today that Afrezza® (insulin human) Inhalation Powder, the only inhaled insulin, is now available by prescription in U.S. retail pharmacies…
Global Market for Intravenous Therapy & Vein Access to Reach $27.2 Billion in 2019
BCC Research anticipates that increasing competition, patent expirations, and evolving customer needs will influence research and development (R&D) spending in the intravenous (IV) therapy and…
Continuous Glucose Monitoring Market Surging at 19.6% CAGR; R&D Soon to Create Devices for Faster Administration
BCC Research (www.bccresearch.com) reveals in its new report on continuous glucose monitoring (CGM), the total CGM market is forecast to reach a value of at…
Colorectal Cancer Treatment Market Value to Hit $9.4 Billion
The value of the Colorectal Cancer (CRC) therapeutics market will increase moderately, from $8.3 billion in 2013 to $9.4 billion by 2020, representing a Compound…
Asia-Pacific Continues to Drive Global Healthcare Investment, Innovation & Growth
The dynamic healthcare landscape across the Asia-Pacific is expected to continue its strong growth momentum in areas of new entities, investments and products, with the…
